Mustafa Hamidullah Turkkani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mustafa Hamidullah Turkkani has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Tarkan Ozdemir
Department of Pulmonology, University of Health Sciences, Ankara Ataturk Sanatorium Training and Research Hospital, Kecioren, Ankara, Turkey
8 shared publications - Çiğdem Özdilekcan
Department of Chest Diseases, Ankara Oncology Training and Research Hospital, Ankara 06200, Turkey
5 shared publications - Ayhan Cosgun
Department of Cardiology, Cihanbeyli State Hospital, Konya, Türkiye
3 shared publications - Ibrahim Halil Akkus
Elazığ Public Health Directorate Department of Family Medicine, Elazığ
2 shared publications Leyla Yilmaz Aydin
2 shared publications- Naim Ata
Department of Strategy, Ministry of Health, 06100 Ankara, Türkiye
2 shared publications
Latest Publications
- Open Access
Comorbidity Burden in Lung Cancer and Malignant Pleural Mesothelioma: Nationwide Database Results of Turkey
Background and Objectives: The presence of comorbidities in both the pre- and post-diagnostic periods is a critical consideration in the diagnosis and management of patients with cancer. This study aimed to investigate the prevalence and burden of pulmonary and extrapulmonary comorbidities in patients diagnosed with lung cancer (LC) and malignant pleural mesothelioma (MPM). Materials and Methods: The data were obtained from official patient records of the Turkish Ministry of Health. Patients diagnosed with either lung cancer (LC) or malignant pleural mesothelioma (MPM) between 2015 and 2018 were included in the study. Comorbidities were classified as pulmonary or extrapulmonary. Results: A total of 74,835 patients with LC and 1678 patients with MPM were included. The burden of comorbid conditions increased significantly in the post-diagnostic period in both males and females across both cancer types. When the two cancer groups were compared with respect to diagnostic periods, comorbidities such as hypertension (HT), phlebitis/venous thrombosis/thrombophlebitis, pulmonary embolism, pneumothorax, and pleural effusion were significantly more prevalent in the MPM group (p < 0.05). Compared with the pre-diagnostic period, the comorbidity risk in LC was highest for pulmonary embolism, ARF, and pneumonia in the post-diagnostic period, whereas renal failure was the most frequent comorbidity in the MPM group (p < 0.001 and p = 0.024). When comparing changes in comorbidity burden between sexes in the lung cancer group, male patients had higher frequencies of pulmonary embolism, pneumonia, pneumothorax, and coronary artery disease than females. In contrast, in the female lung cancer group, the prevalence of chronic renal failure was higher than in males (OR = 2.14 vs. 2.00), whereas acute renal failure was more prominent in the male patient group (OR = 2.64 vs. 1.94). In gender-based comparison of comorbid conditions among patients with MPM, the risk of renal failure was higher in females than in males (CRF and ARF respectively: OR = 2.63 vs. 2.16 and OR = 6.80 vs. 5.44). Additionally, increased rates of COPD were observed in male patients within this group (OR = 1.93 vs. 1.81). Conclusions: Patients with LC and MPM are burdened not only by their primary malignancies but also by a wide spectrum of comorbidities, particularly in the post-diagnostic period. Comprehensive knowledge of comorbid conditions is essential for clinicians to guide clinical decision-making, anticipate disease progression, and optimize treatment strategies, thereby informing national healthcare policies. Future studies incorporating matched control groups or longitudinal designs with standardized surveillance protocols may help conduct better research.
Open AccessComorbidity Burden in Lung Cancer and Malignant Pleural Mesothelioma: Nationwide Database Results of Turkey
Background and Objectives: The presence of comorbidities in both the pre- and post-diagnostic periods is a critical consideration in the diagnosis and management of patients with cancer. This study aimed to investigate the prevalence and burden of pulmonary and extrapulmonary comorbidities in patients diagnosed with lung cancer (LC) and malignant pleural mesothelioma (MPM). Materials and Methods: The data were obtained from official patient records of the Turkish Ministry of Health. Patients diagnosed with either lung cancer (LC) or malignant pleural mesothelioma (MPM) between 2015 and 2018 were included in the study. Comorbidities were classified as pulmonary or extrapulmonary. Results: A total of 74,835 patients with LC and 1678 patients with MPM were included. The burden of comorbid conditions increased significantly in the post-diagnostic period in both males and females across both cancer types. When the two cancer groups were compared with respect to diagnostic periods, comorbidities such as hypertension (HT), phlebitis/venous thrombosis/thrombophlebitis, pulmonary embolism, pneumothorax, and pleural effusion were significantly more prevalent in the MPM group (p < 0.05). Compared with the pre-diagnostic period, the comorbidity risk in LC was highest for pulmonary embolism, ARF, and pneumonia in the post-diagnostic period, whereas renal failure was the most frequent comorbidity in the MPM group (p < 0.001 and p = 0.024). When comparing changes in comorbidity burden between sexes in the lung cancer group, male patients had higher frequencies of pulmonary embolism, pneumonia, pneumothorax, and coronary artery disease than females. In contrast, in the female lung cancer group, the prevalence of chronic renal failure was higher than in males (OR = 2.14 vs. 2.00), whereas acute renal failure was more prominent in the male patient group (OR = 2.64 vs. 1.94). In gender-based comparison of comorbid conditions among patients with MPM, the risk of renal failure was higher in females than in males (CRF and ARF respectively: OR = 2.63 vs. 2.16 and OR = 6.80 vs. 5.44). Additionally, increased rates of COPD were observed in male patients within this group (OR = 1.93 vs. 1.81). Conclusions: Patients with LC and MPM are burdened not only by their primary malignancies but also by a wide spectrum of comorbidities, particularly in the post-diagnostic period. Comprehensive knowledge of comorbid conditions is essential for clinicians to guide clinical decision-making, anticipate disease progression, and optimize treatment strategies, thereby informing national healthcare policies. Future studies incorporating matched control groups or longitudinal designs with standardized surveillance protocols may help conduct better research.
- Open Access
- 14 April 2026
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 56 (2) , 509-517
Asthma data in Türkiye between 2016 and 2022: a nationwide descriptive and observational study covering the entire adult population
Background/aim: Determining the current burden of asthma in countries is important in the diagnosis and follow-up of asthma patients and for the development of national health policies. Our study aimed to clarify the epidemiological and clinical data regarding asthmatic adults in Türkiye. Materials and methods: The study was designed as a nationwide descriptive, observational cross-sectional study. Data on adult patients who were followed with the diagnosis of asthma in all public, private, and university hospitals in Türkiye between January 2016 and December 2022 were obtained from the e-Nabız database of the Ministry of Health and analyzed. Results: The number of patients followed with a diagnosis of asthma in Türkiye between 2016 and 2022 was 2,700,183. The mean age of these patients was 45.70 years (standard deviation: 15.87) and 74.5% of them were female. Of the patients, 92.3% were prescribed dry powder inhalers, 98.41% metered dose inhalers, and 80.38% montelukast. The short-acting beta-2 agonist (SABA) prescription rate was 65.74% and SABA was prescribed as the sole medication for 0.10% of patients. The percentage of patients prescribed nebulized treatment was found to be 69.83%. Among asthmatic adults, the rate of at least one emergency room visit was 12.4%, the rate of hospitalization in the ward was 5.6%, and the rate of intensive care unit admission was 0.1%. Conclusion: Asthma is a major health burden in Türkiye, as is the case around the world. National planning for the diagnosis and follow-up of patients needs to be improved and continued.
- 14 April 2026
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 56 (2) , 509-517
Open AccessAsthma data in Türkiye between 2016 and 2022: a nationwide descriptive and observational study covering the entire adult population
Background/aim: Determining the current burden of asthma in countries is important in the diagnosis and follow-up of asthma patients and for the development of national health policies. Our study aimed to clarify the epidemiological and clinical data regarding asthmatic adults in Türkiye. Materials and methods: The study was designed as a nationwide descriptive, observational cross-sectional study. Data on adult patients who were followed with the diagnosis of asthma in all public, private, and university hospitals in Türkiye between January 2016 and December 2022 were obtained from the e-Nabız database of the Ministry of Health and analyzed. Results: The number of patients followed with a diagnosis of asthma in Türkiye between 2016 and 2022 was 2,700,183. The mean age of these patients was 45.70 years (standard deviation: 15.87) and 74.5% of them were female. Of the patients, 92.3% were prescribed dry powder inhalers, 98.41% metered dose inhalers, and 80.38% montelukast. The short-acting beta-2 agonist (SABA) prescription rate was 65.74% and SABA was prescribed as the sole medication for 0.10% of patients. The percentage of patients prescribed nebulized treatment was found to be 69.83%. Among asthmatic adults, the rate of at least one emergency room visit was 12.4%, the rate of hospitalization in the ward was 5.6%, and the rate of intensive care unit admission was 0.1%. Conclusion: Asthma is a major health burden in Türkiye, as is the case around the world. National planning for the diagnosis and follow-up of patients needs to be improved and continued.
- Open Access
- 1 May 2023
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 24 (3) , 151-156
Factors Affecting Smoking Cessation After Acute Myocardial Infarction
Acute myocardial infarction,nicotine dependence,smoking cessation,tobacco control
- 1 May 2023
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 24 (3) , 151-156
Open AccessFactors Affecting Smoking Cessation After Acute Myocardial Infarction
Acute myocardial infarction,nicotine dependence,smoking cessation,tobacco control
- 14 July 2022
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 16 (12) , 925-933
Is There A Relationship Between Epicardial Adipose Tissue, Inflammatory Markers and Prognosis in Covid-19 in Patients Under 65 Years?
Aim: This study investigated the prognostic value of epicardial adipose tissue volume (EATV) attenuation (EATA) in patients admitted to the intensive care unit for COVID-19. Materials & methods: C-...
- 14 July 2022
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 16 (12) , 925-933
Is There A Relationship Between Epicardial Adipose Tissue, Inflammatory Markers and Prognosis in Covid-19 in Patients Under 65 Years?
Aim: This study investigated the prognostic value of epicardial adipose tissue volume (EATV) attenuation (EATA) in patients admitted to the intensive care unit for COVID-19. Materials & methods: C-...
- 15 October 2021
- Published by Galenos Yayinevi in Turkish Thoracic Journal
- Vol. 22 (5) , 393-398
Five-Year Trends in Direct Costs of Chronic Obstructive Pulmonary Disease in Turkey: COPDTURKEY-3
Mean cost per patient,mean cost per visit,mean cost per hospitalization,outpatient cost,inpatient cost
- 15 October 2021
- Published by Galenos Yayinevi in Turkish Thoracic Journal
- Vol. 22 (5) , 393-398
Five-Year Trends in Direct Costs of Chronic Obstructive Pulmonary Disease in Turkey: COPDTURKEY-3
Mean cost per patient,mean cost per visit,mean cost per hospitalization,outpatient cost,inpatient cost
- 10 December 2020
- Published by Maad Rayan Publishing Company in Journal of Research in Clinical Medicine
- Vol. 9 (1) , 5
The Relationships between the Repolarisation and Depolarisation Markers of Sudden Cardiac Death in Smokers
Backgroung: The risk of sudden cardiac death (SCD) and atrial fibrillation (AF) increase in smokers. This study aimed to determine the relationships between the repolarization and depolarization predictors of SCD in routine electrocardiography (ECG) in smokers. Methods: Between January and August-2019, ninety-eight healthy patients smoking for more than five years were included in the study group by simple random sampling. The control group consisted of one hundred twenty-two non-smokers. In the study and control group, following a routine physical examination and blood tests, P wave dispersion in the right precordial leads (PWdR) and the left precordial leads (PWdL), T peak-end interval in the right precordial leads (Tp-eR) and the left precordial leads (Tp-eL), QRS dispersion in the right precordial leads (dQRSR) and the left precordial leads (dQRSL), and QRS duration values in the right precordial leads (QRSR) and the left precordial leads (QRSL) were calculated in routine 12-lead ECG + right precordial leads. Results: There was a statistically significant moderate positive correlation between dQRSRxTp-eR/QRSR-value and smoking time in the study group. Also, there was a statistically significant weak negative correlation between dQRSLxTp-eL/QRSL-value and smoking time in the study group (Respectively, R=0.52, and P<0.01, R=0.41 and P<0.01). There was a significant difference between correlation ratio of dQRSRxTp-eR/QRS-value and smoking time and dQRSLxTp-eL/QRSL-value and smoking time in the study group (Z=5.73, p<0.01). Conclusions: In the current smokers, dQRSRxTp-eR/QRSR and dQRSLxTp-eL/QRSL values significantly higher than in the control group.
- 10 December 2020
- Published by Maad Rayan Publishing Company in Journal of Research in Clinical Medicine
- Vol. 9 (1) , 5
The Relationships between the Repolarisation and Depolarisation Markers of Sudden Cardiac Death in Smokers
Backgroung: The risk of sudden cardiac death (SCD) and atrial fibrillation (AF) increase in smokers. This study aimed to determine the relationships between the repolarization and depolarization predictors of SCD in routine electrocardiography (ECG) in smokers. Methods: Between January and August-2019, ninety-eight healthy patients smoking for more than five years were included in the study group by simple random sampling. The control group consisted of one hundred twenty-two non-smokers. In the study and control group, following a routine physical examination and blood tests, P wave dispersion in the right precordial leads (PWdR) and the left precordial leads (PWdL), T peak-end interval in the right precordial leads (Tp-eR) and the left precordial leads (Tp-eL), QRS dispersion in the right precordial leads (dQRSR) and the left precordial leads (dQRSL), and QRS duration values in the right precordial leads (QRSR) and the left precordial leads (QRSL) were calculated in routine 12-lead ECG + right precordial leads. Results: There was a statistically significant moderate positive correlation between dQRSRxTp-eR/QRSR-value and smoking time in the study group. Also, there was a statistically significant weak negative correlation between dQRSLxTp-eL/QRSL-value and smoking time in the study group (Respectively, R=0.52, and P<0.01, R=0.41 and P<0.01). There was a significant difference between correlation ratio of dQRSRxTp-eR/QRS-value and smoking time and dQRSLxTp-eL/QRSL-value and smoking time in the study group (Z=5.73, p<0.01). Conclusions: In the current smokers, dQRSRxTp-eR/QRSR and dQRSLxTp-eL/QRSL values significantly higher than in the control group.
- Open Access
- 5 May 2020
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 50 (5) , 1371-1379
Determination of related factors about diagnostic and treatment delays in patients with smear-positive pulmonary tuberculosis in Turkey
Background/aim: This study aimed to analyze delays in diagnosis and treatment by defining the related demographic and clinical factors, to reveal obstacles, and to develop essential attempts to help reduce treatment delays. Materials and methods: We created a questionnaire on the subject of delays in diagnosis and treatment in tuberculosis (TB) control to be administered to the patients. The forms were distributed to dispensaries across the country by the General Directorate of Public Health via an official letter. Results: The study included 853 new patients with smear-positive pulmonary TB. The mean patient delay was 18.06 +/- 22.27 days, the mean diagnosis delay was 35.63 +/- 34.86 days, and the mean treatment delay was 0.90 +/- 2.39 days. We found no association between sex, age, literacy, residential location, the presence of chronic respiratory diseases, and patient delay. It was determined that patient delay was shorter for patients with hemoptysis, fever, dyspnoea, and chest pain. In women, the diagnosis delay was longer than in men. Conclusion: In the diagnosis process of patients with tuberculosis, it was determined that there was an improvement in the patient delay; however, the improvement in the diagnosis delay was still not acceptable as an ideal duration.
- 5 May 2020
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 50 (5) , 1371-1379
Open AccessDetermination of related factors about diagnostic and treatment delays in patients with smear-positive pulmonary tuberculosis in Turkey
Background/aim: This study aimed to analyze delays in diagnosis and treatment by defining the related demographic and clinical factors, to reveal obstacles, and to develop essential attempts to help reduce treatment delays. Materials and methods: We created a questionnaire on the subject of delays in diagnosis and treatment in tuberculosis (TB) control to be administered to the patients. The forms were distributed to dispensaries across the country by the General Directorate of Public Health via an official letter. Results: The study included 853 new patients with smear-positive pulmonary TB. The mean patient delay was 18.06 +/- 22.27 days, the mean diagnosis delay was 35.63 +/- 34.86 days, and the mean treatment delay was 0.90 +/- 2.39 days. We found no association between sex, age, literacy, residential location, the presence of chronic respiratory diseases, and patient delay. It was determined that patient delay was shorter for patients with hemoptysis, fever, dyspnoea, and chest pain. In women, the diagnosis delay was longer than in men. Conclusion: In the diagnosis process of patients with tuberculosis, it was determined that there was an improvement in the patient delay; however, the improvement in the diagnosis delay was still not acceptable as an ideal duration.
- 1 May 2020
- Published by AVES YAYINCILIK A.Ş. in Balkan Medical Journal
- Vol. 37 (3) , 157-162
The Geographical Distribution of Morbidity Caused By Chronic Obstructive Pulmonary Disease in Turkey: COPDTURKEY-2
Background: Chronic obstructive pulmonary disease (COPD) is one of the most prevalent causes for morbidity and mortality, and it creates a cumulative economic and social burden. Aims: To determine the distribution of the prevalence of patients in Turkey who were diagnosed with COPD and their morbidity rates, according to the regions and cities they belong to. Moreover, the study contributes to the prevention and cure services of COPD that should be planned in the future. Study Design: A retrospective cohort. Methods: The database of the Social Security Institution from 2016 has been scanned. All the data with prescription registration, with the code ICD-10, J44.0-J44.9, which were aimed for diagnosing and/or cure, have been evaluated with a retrospective cohort. Results: In 2016, 955,369 patients who were admitted as outpatients to the hospitals were diagnosed with COPD. The average number of annual COPD cases that were admitted was 2.09. Twenty percent (20%) of the outpatient applications were via emergency room. The rate of hospitalization among the applicants was 17.75%. with a total of 1,994,325. The average annual number of hospitalizations of men was higher than that of women. The average number of hospitalization days was 6.52. The region with the highest prevalence of outpatient admission and hospitalization was the Black Sea Region. Conclusion: The high rate of hospitalization was considered to be the outcome of the insufficient "outpatient" management.
- 1 May 2020
- Published by AVES YAYINCILIK A.Ş. in Balkan Medical Journal
- Vol. 37 (3) , 157-162
The Geographical Distribution of Morbidity Caused By Chronic Obstructive Pulmonary Disease in Turkey: COPDTURKEY-2
Background: Chronic obstructive pulmonary disease (COPD) is one of the most prevalent causes for morbidity and mortality, and it creates a cumulative economic and social burden. Aims: To determine the distribution of the prevalence of patients in Turkey who were diagnosed with COPD and their morbidity rates, according to the regions and cities they belong to. Moreover, the study contributes to the prevention and cure services of COPD that should be planned in the future. Study Design: A retrospective cohort. Methods: The database of the Social Security Institution from 2016 has been scanned. All the data with prescription registration, with the code ICD-10, J44.0-J44.9, which were aimed for diagnosing and/or cure, have been evaluated with a retrospective cohort. Results: In 2016, 955,369 patients who were admitted as outpatients to the hospitals were diagnosed with COPD. The average number of annual COPD cases that were admitted was 2.09. Twenty percent (20%) of the outpatient applications were via emergency room. The rate of hospitalization among the applicants was 17.75%. with a total of 1,994,325. The average annual number of hospitalizations of men was higher than that of women. The average number of hospitalization days was 6.52. The region with the highest prevalence of outpatient admission and hospitalization was the Black Sea Region. Conclusion: The high rate of hospitalization was considered to be the outcome of the insufficient "outpatient" management.
- 31 March 2020
- Published by Cagdas Tip Dergisi: Journal of Contemporary Medicine in Journal of Contemporary Medicine
- Vol. 10 (1) , 35-39
Analysis of the relationship between smoking and chronic respiratory symptoms, level of income and education
Objective: In this study, we aimed to determine the general demographic characteristics of smokers and to define the association of smoking with respiratory symptoms, level of education and income.Materials and Methods: This prospective study was conducted on 1019 people aged 40 and over. A questionnaire containing questions about respiratory symptoms, tobacco use and risk factors for chronic respiratory diseases was applied to all the participants. The study participants were grouped regarding their smoking status as current smokers, never smokers and former smokers. Age, gender, marital status, education level, monthly income per house person were recorded for all participants.Results: 1019 people with a mean age of 53.20 ±9.06 years (range: 40-90 years) were included in the study. Among females, 72/486 were active smoker; while in males 226/533 were active smoker (p:0.001). Mid- high school and university graduates were more commonly smoker or former-smoker. Participants with higher monthly income per house person (> 1000 TRY) were significantly more commonly active-smoker. Cough and sputum for longer than 3 months was determined in 66 (6.5%) people while the triad of cough and sputum for longer than 3 months and dyspnea was determined in 36 (3.5%) people. Among those participants the ratio of smokers was significantly higher. A significant proportion of participants (63.8%) with the symptoms predicting chronic pulmonary diseases, were not having diagnosis of any chronic respiratory disease before.Conclusion: We determined that; unlike the previous reports educated and higher monthly income people were more commonly smoker. We also found that chronic respiratory diseases is not sufficiently diagnosed. In screening for early diagnosis of chronic pulmonary diseases, we think that symptomatic interrogation is still important for selection of target population.
- 31 March 2020
- Published by Cagdas Tip Dergisi: Journal of Contemporary Medicine in Journal of Contemporary Medicine
- Vol. 10 (1) , 35-39
Analysis of the relationship between smoking and chronic respiratory symptoms, level of income and education
Objective: In this study, we aimed to determine the general demographic characteristics of smokers and to define the association of smoking with respiratory symptoms, level of education and income.Materials and Methods: This prospective study was conducted on 1019 people aged 40 and over. A questionnaire containing questions about respiratory symptoms, tobacco use and risk factors for chronic respiratory diseases was applied to all the participants. The study participants were grouped regarding their smoking status as current smokers, never smokers and former smokers. Age, gender, marital status, education level, monthly income per house person were recorded for all participants.Results: 1019 people with a mean age of 53.20 ±9.06 years (range: 40-90 years) were included in the study. Among females, 72/486 were active smoker; while in males 226/533 were active smoker (p:0.001). Mid- high school and university graduates were more commonly smoker or former-smoker. Participants with higher monthly income per house person (> 1000 TRY) were significantly more commonly active-smoker. Cough and sputum for longer than 3 months was determined in 66 (6.5%) people while the triad of cough and sputum for longer than 3 months and dyspnea was determined in 36 (3.5%) people. Among those participants the ratio of smokers was significantly higher. A significant proportion of participants (63.8%) with the symptoms predicting chronic pulmonary diseases, were not having diagnosis of any chronic respiratory disease before.Conclusion: We determined that; unlike the previous reports educated and higher monthly income people were more commonly smoker. We also found that chronic respiratory diseases is not sufficiently diagnosed. In screening for early diagnosis of chronic pulmonary diseases, we think that symptomatic interrogation is still important for selection of target population.
- Open Access
- 1 January 2020
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 50 (1) , 141-147
Patients with COPD who underwent pulmonary rehabilitation in Turkey: prevalence, distribution, and mortality.
Pulmonary rehabilitation (PR) is an effective, evidenced-based treatment. Despite its proven effect, it is still underused. The aim of this study was to present the number of patients with chronic obstructive pulmonary disease (COPD) who underwent PR, general mortality percentages, the rate of patients prescribed PR by pulmonologists, and the distribution of institutions where PR was performed between 2008 and 2016 in Turkey. The documents were obtained from Turkish Institution of Social Insurance. Ages, sexes, and numbers of patients with COPD who underwent PR between 2008 and 2016 were recorded. The number of patients with COPD who had been prescribed PR by physicians and the type of hospitals in which these patients underwent PR were identified. The general annual and the general total mortality rates between 2008 and 2016 among patients with COPD who underwent PR in 2008 were also determined. The mean age ranges of patients with COPD who underwent PR were 67.4 ± 12.3 to 72.0 ± 13.2 years, and 62.2% (n = 60,852) of patients were male. The number of patients increased progressively from 3,214 to 18,664. The rate of patients prescribed PR programs between 2008 and 2016 was between 0.32% and 0.59% among all registered patients with COPD. Between 52.0% and 94.8% (5,488/10,549 and 16,792/17,707 patients, respectively) of the programs were prescribed by a pulmonologist, and 62.9% (n = 62,613) of patients received PR in secondary public hospitals. The general annual mortality rates were between 6.2% and 11.1% (115/1,855 and 358/3,214 patients) in patients who underwent PR in 2008, and the general total mortality rate was 52.8% (1,696/3,214 patients) over the 9-year period in the same patient group. PR was still an underutilized approach in Turkey between 2008 and 2016. The awareness of PR should be increased in our country. In order to achieve this, we think that PR should be within the scope of health policies.
- 1 January 2020
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 50 (1) , 141-147
Open AccessPatients with COPD who underwent pulmonary rehabilitation in Turkey: prevalence, distribution, and mortality.
Pulmonary rehabilitation (PR) is an effective, evidenced-based treatment. Despite its proven effect, it is still underused. The aim of this study was to present the number of patients with chronic obstructive pulmonary disease (COPD) who underwent PR, general mortality percentages, the rate of patients prescribed PR by pulmonologists, and the distribution of institutions where PR was performed between 2008 and 2016 in Turkey. The documents were obtained from Turkish Institution of Social Insurance. Ages, sexes, and numbers of patients with COPD who underwent PR between 2008 and 2016 were recorded. The number of patients with COPD who had been prescribed PR by physicians and the type of hospitals in which these patients underwent PR were identified. The general annual and the general total mortality rates between 2008 and 2016 among patients with COPD who underwent PR in 2008 were also determined. The mean age ranges of patients with COPD who underwent PR were 67.4 ± 12.3 to 72.0 ± 13.2 years, and 62.2% (n = 60,852) of patients were male. The number of patients increased progressively from 3,214 to 18,664. The rate of patients prescribed PR programs between 2008 and 2016 was between 0.32% and 0.59% among all registered patients with COPD. Between 52.0% and 94.8% (5,488/10,549 and 16,792/17,707 patients, respectively) of the programs were prescribed by a pulmonologist, and 62.9% (n = 62,613) of patients received PR in secondary public hospitals. The general annual mortality rates were between 6.2% and 11.1% (115/1,855 and 358/3,214 patients) in patients who underwent PR in 2008, and the general total mortality rate was 52.8% (1,696/3,214 patients) over the 9-year period in the same patient group. PR was still an underutilized approach in Turkey between 2008 and 2016. The awareness of PR should be increased in our country. In order to achieve this, we think that PR should be within the scope of health policies.